Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamamatsu Introduces New S12572 Series of MPPC Devices

Published: Tuesday, October 08, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
New improved MPPC for general photon counting applications.

Hamamatsu Photonics have expanded and improved on their range of semi-conductor detectors, featuring photon counting capability, with the introduction of the brand new S12572 series of multi-pixel photon counter devices (MPPC).

This new series of general purpose MPPC offers drastically reduced afterpulsing compared to previous Hamamatsu MPPC detectors.

The S12572 series are 3x3mm devices supplied in compact surface mount plastic packages, or through-hole ceramic packages.

Various pixel configurations are available, with pitches of 25um, 50um and 100um and pixel numbers of 14,400, 3,600 and 900 respectively.

Each pixel contains a quenching resistor so that simultaneous photon events can be counted separately and with a high degree of accuracy.

The devices feature typical high gain values of 5.15E5 to 2.8E6, comparable to that achievable from a conventional photomultiplier tube.

Some other key areas of improvement to the MPPC include; greatly reduced dark count, reduced afterpulsing, increased photon detection efficiency, improvements in timing resolution and linearity as well as reduced crosstalk.

The result of these and other improvements means that the MPPC now has a much improved signal-to-noise ratio, wider operating voltage range, improved time resolution and a wider dynamic range.

With these improvements, the S12572 series are ideal for a variety of applications, including positron emission tomography, high-energy physics, DNA sequencing, fluorescence measurement, nuclear medicine, point of care systems, drug discovery, medical diagnostic equipment and environmental analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!